Scientists Prevail in J&J’s Defamation Lawsuit Over Talc Research

A federal judge has ruled in favor of three scientists sued by a Johnson & Johnson subsidiary over a study examining cosmetic talc exposure and mesothelioma. The subsidiary alleged that statements in the study harmed the reputation of its talc products. The court found insufficient evidence that the researchers published the challenged statements knowing they were false or while seriously doubting their accuracy. The ruling addresses the lawsuit over the talc research, not whether any talc product caused a person’s cancer.

Background of J&J’s Defamation Lawsuit Over Talc Research

In March 2020, Dr. Theresa Emory, Dr. John Maddox, and Dr. Richard Kradin published a study in the American Journal of Industrial Medicine, examining 75 people diagnosed with mesothelioma. The researchers reported that repeated use of cosmetic talcum powder was the patients’ only known asbestos exposure. Their paper concluded that mesothelioma can develop following exposure to cosmetic talc products containing certain mineral contaminants.

Pecos River Talc LLC, a Johnson & Johnson subsidiary, challenged statements about how the researchers identified patients’ exposures, whether the group was distinct from patients described in earlier research, and whether cosmetic talc was their only known source of asbestos exposure. Its lawsuit against the researchers was for trade libel, which concerns allegedly false statements that harm a product or business. 

J&J Raises Allegations of Malice

A central dispute in J&J’s lawsuit concerned the researchers’ description of 75 new patients in the study group. Pecos River argued that eight of those patients also appeared in an earlier study and that the researchers either knew about the overlap or recklessly disregarded it. The subsidiary also disputed the researchers’ descriptions of their review process and the patients’ other potential asbestos exposures.

The court acknowledged that eight patients overlapped with the earlier research. But the question it had to decide was whether Pecos River had presented enough evidence of actual malice: knowledge that a challenged statement was false or reckless disregard for its truth. Establishing an error alone would not meet that standard. 

District Court Rules in Favor of Scientists

On August 19, 2026, U.S. District Judge Jamar Walker granted the researchers’ motion for summary judgment and entered judgment in their favor. He found that Pecos River had not produced evidence from which a reasonable jury could find actual malice under the required standard. 

The ruling describes efforts by Emory to identify possible duplicate patients before publication. She compared information from the two studies, sought help checking potential overlaps, and removed four patients she believed might have appeared in the earlier research. Although additional overlaps remained, the judge found insufficient evidence that the researchers knowingly published a false statement or deliberately avoided information that would show it was false.

The court also examined Pecos River’s objections to statements about patient exposure histories and the materials the researchers reviewed. It concluded that the evidence did not establish the researchers’ required state of mind when they published those statements. The judge did not decide whether every challenged statement was accurate or whether the study’s conclusions about talc and mesothelioma were scientifically correct.

Implications for Johnson & Johnson

The decision ends Pecos River’s trade libel claim against these three researchers at the district court level. It does not determine whether Johnson & Johnson’s talcum powder products caused cancer, or whether people pursuing product liability claims can establish liability. Those questions remain distinct from the issue the Virginia court decided: whether Pecos River had enough evidence to proceed with its claim about the researchers’ statements. Johnson & Johnson continues to maintain that its talc products are safe and do not cause cancer. 

Lawsuits Alleging a Link Between Talcum Powder and Cancer

Johnson & Johnson has faced tens of thousands of lawsuits alleging that its talc products caused mesothelioma or ovarian cancer. The allegations differ: mesothelioma claims have focused on alleged asbestos contamination, while ovarian cancer claims have raised questions about talc use and cancer risk. The company disputes these claims.

In July 2026, Johnson & Johnson announced a proposed $5.5 billion resolution of remaining ovarian talc claims, subject to conditions that include participation by at least 95% of the remaining claimants. The company said it had separately settled approximately 95% of filed mesothelioma lawsuits. The proposed talcum powder cancer settlement is separate from the researchers’ defamation lawsuit.

What the Federal Court’s Ruling Leaves Open

The Virginia ruling resolves a dispute about the researchers’ alleged conduct in publishing their study. It does not settle the scientific debate about cosmetic talc or decide the outcome of individual talcum powder cancer claims.